{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:56:50Z","timestamp":1760709410160},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.prp.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T07:03:34Z","timestamp":1505804614000},"page":"1378-1383","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features"],"prefix":"10.1016","volume":"213","author":[{"given":"Takuro","family":"Igawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Miyatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.09.015_bib0005","first-page":"2253","article-title":"Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma","volume":"95","author":"Yatabe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.09.015_bib0010","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2017.09.015_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1440-1827.2001.01277.x","article-title":"Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases","volume":"51","author":"Yatabe","year":"2001","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2017.09.015_bib0020","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","article-title":"Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants","volume":"15","author":"Majlis","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2017.09.015_bib0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2017.09.015_bib0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2017.09.015_bib0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.09.015_bib0040","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients","volume":"3","author":"Frizzera","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2017.09.015_bib0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02841860410002752","article-title":"Fifty years of multicentric Castleman's disease","volume":"43","author":"Waterston","year":"2004","journal-title":"Acta Oncol."},{"key":"10.1016\/j.prp.2017.09.015_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3960\/jslrt.51.147","article-title":"Mantle cell lymphoma superimposed on multicentric Castleman's disease","volume":"51","author":"Yoshida","year":"2011","journal-title":"J. Clin. Exp. Hematop."},{"key":"10.1016\/j.prp.2017.09.015_bib0055","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Campo","year":"2008"},{"key":"10.1016\/j.prp.2017.09.015_bib0060","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0002-9440(10)65399-0","article-title":"Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization","volume":"154","author":"Li","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2017.09.015_bib0065","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2017.09.015_bib0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/jcp.2010.082958","article-title":"Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases","volume":"63","author":"Sato","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.09.015_bib0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients","volume":"86","author":"Lachenal","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.prp.2017.09.015_bib0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2559.2005.02309.x","article-title":"A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases","volume":"48","author":"Traverse-Glehen","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2017.09.015_bib0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"I.M.W. Group","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2017.09.015_bib0090","first-page":"1147","article-title":"In situ mantle cell lymphoma associated with hyaline-vascular Castleman disease","volume":"52","author":"Dobrea","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.prp.2017.09.015_bib0095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1309\/AJCPF5AESY7OWIXF","article-title":"B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study","volume":"135","author":"Siddiqi","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.09.015_bib0100","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.09.015_bib0105","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.09.015_bib0110","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V78.11.2923.2923","article-title":"Interleukin-6 gene expression in Castleman's disease","volume":"78","author":"Leger-Ravet","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.09.015_bib0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1440-1827.2001.01266.x","article-title":"HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease","volume":"51","author":"Suda","year":"2001","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2017.09.015_bib0120","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/leu.2015.140","article-title":"Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1","volume":"30","author":"Teo","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.prp.2017.09.015_bib0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/his.12213","article-title":"Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall","volume":"63","author":"Liu","year":"2013","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.prp.2017.09.015_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2559.1989.tb02162.x","article-title":"An immunohistological and genotypic study of the plasma cell form of Castleman's disease","volume":"14","author":"Hall","year":"1989","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.prp.2017.09.015_bib0135","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-02-179739","article-title":"How I treat mantle cell lymphoma","volume":"114","author":"Ghielmini","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.prp.2017.09.015_bib0140","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817306842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817306842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T17:30:12Z","timestamp":1584120612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817306842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0344033817306842"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.09.015","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}